Literature DB >> 28228433

Case of primary bilateral diffuse large B-cell lymphoma of the ovary with plasmablastic features in an HIV-negative female patient.

Suvarna L Guvvala1, Sailaja Sakam1, Masooma Niazi2, Yevgeniy Skaradinskiy1,3.   

Abstract

A 37-year-old woman from Puerto Rico presented to our clinic with symptoms of an abdominal distension progressively worsening over 1 year. A CT of an abdomen and pelvis with contrast was performed and revealed bilateral large heterogeneous pelvic adnexal masses with large ascites and right pleural effusion. Tumour markers CA 125 was 766 U/mL and lactate dehydrogenase was 654 U/L. She underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy with pelvic lymph node dissection and partial omentectomy. Pathology of ovarian masses revealed a diffuse large B-cell lymphoma. The staging work-up was negative, which pointed towards the diagnosis of primary ovarian lymphoma. The patient completed 8 cycles of cyclophosphamide, doxorubicin, vincristine, prednisolone chemotherapy. After 18 months of chemotherapy completion, she remains in remission. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28228433      PMCID: PMC5337685          DOI: 10.1136/bcr-2016-218117

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.

Authors:  W M Tai; J Chung; P L Tang; Y X Koo; X Hou; K W Tay; R Quek; M Tao; S T Lim
Journal:  Ann Hematol       Date:  2011-01-13       Impact factor: 3.673

2.  Primary ovarian large B-cell lymphoma in patient with juvenile rheumatoid arthritis treated with low dose Methotrexate.

Authors:  Yusuf Yildirim
Journal:  Gynecol Oncol       Date:  2005-04       Impact factor: 5.482

3.  Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: analyses with competing risk regression model.

Authors:  Dai Chihara; Yasuhiro Oki; Keitaro Matsuo; Hiroshi Onoda; Hirofumi Taji; Kazuhito Yamamoto; Yasuo Morishima
Journal:  Leuk Lymphoma       Date:  2011-07-12

Review 4.  Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis.

Authors:  Jing Zhang; Bobin Chen; Xiaoping Xu
Journal:  Leuk Lymphoma       Date:  2013-07-29

Review 5.  Non-Hodgkin malignant lymphoma revealed by an ovarian tumor case report and review of the literature.

Authors:  A S Weingertner; D Hamid; M N Roedlich; J J Baldauf
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

6.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.

Authors:  H J Delecluse; I Anagnostopoulos; F Dallenbach; M Hummel; T Marafioti; U Schneider; D Huhn; A Schmidt-Westhausen; P A Reichart; U Gross; H Stein
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

7.  Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases.

Authors:  B M Osborne; S J Robboy
Journal:  Cancer       Date:  1983-11-15       Impact factor: 6.860

8.  A case of malignant lymphoma of the ovary manifesting like an advanced ovarian cancer.

Authors:  Takashi Yamada; Noriaki Iwao; Hajime Kasamatsu; Hiroshi Mori
Journal:  Gynecol Oncol       Date:  2003-07       Impact factor: 5.482

9.  Malignant lymphoma presenting as an ovarian tumour: a clinicopathological analysis of 34 cases.

Authors:  H Fox; F A Langley; A D Govan; A S Hill; M H Bennett
Journal:  Br J Obstet Gynaecol       Date:  1988-04

10.  New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.

Authors:  Qing-Qing Cai; Li-Yang Hu; Qi-Rong Geng; Jie Chen; Zhen-Hai Lu; Hui-Lan Rao; Qing Liu; Wen-Qi Jiang; Hui-Qiang Huang; Tong-Yu Lin; Zhong-Jun Xia
Journal:  Chin J Cancer       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.